Results 41 to 50 of about 42,441 (299)

Ex-vivo recruitment and x-ray assessment of donor lungs in a challenging retrieval from a donor supported by lvad using the portable normothermic perfusion system: A case report [PDF]

, 2017
Lung transplantation (LTx) is limited by the shortage of suitable donors. To overcome this problem, many programs have begun to use donors with extended criteria (marginal donors).
Calabrese, Fiorella, Calabrese, Francesca, DI GREGORIO, Guido, Loy, Monica, Marulli, Giuseppe, Rea, Federico, Rebusso, Alessandro, Schiavon, Marco   +7 more
core   +1 more source

Implantation of ventricular assist devices in hypertrophic cardiomyopathy with left ventricular systolic dysfunction

ESC Heart Failure, 2021
Aims The outcomes of patients with hypertrophic cardiomyopathy with left ventricular systolic dysfunction (HCM‐LVSD) undergoing left ventricular assist device (LVAD) implantation remain unclear.
Nobuichiro Yagi, Osamu Seguchi, Hiroki Mochizuki, Kensuke Kuroda, Seiko Nakajima, Takuya Watanabe, Masanobu Yanase, Naoki Tadokoro, Satsuki Fukushima, Tomoyuki Fujita, Norihide Fukushima   +10 more
doaj   +1 more source

Successful heart transplantation after 4 years of bridging with HeartWare HVAD for left ventricular noncompaction in an 11-year-old boy with prohibitively high pulmonary vascular resistance

Annals of Pediatric Cardiology
End-stage heart failure due to left ventricular noncompaction (LVNC) poses unique challenges for ventricular assist device implantation, like inflow cannula obstruction due to trabeculations. We report a case of an 11-year-old boy with LVNC who underwent
Komarakshi R. Balakrishnan, Sureshkumaran Kandasami, Suresh Rao Kemundel Genny, Rajesh Kumar Ramaswamy, Ratnagiri Ravikumar   +4 more
doaj   +1 more source

Ophthalmic Surgery in Patients with Left Ventricular Assist Devices

Case Reports in Ophthalmological Medicine, 2019
The newer generation of left ventricular assist devices (LVADs) are commonly used as destination therapy; these devices have demonstrated improved outcomes and increased survival.
George A. Dumas, Ayesha S. Bryant, Gwendolyn L. Boyd   +2 more
doaj   +1 more source

Value of nutritional indices in predicting survival free from pump replacement and driveline infections in centrifugal left ventricular assist devicesCentral MessagePerspective

JTCVS Open
Objective: There is a paucity of data assessing the impact of nutritional status on outcomes in patients supported with the HeartMate 3 (HM3) left ventricular assist device (LVAD).
Fabian Jimenez Contreras, MD, Bret L. Pinsker, MD, Jason N. Katz, MD, MHS, Stuart D. Russell, MD, Jacob Schroder, MD, Benjamin Bryner, MD, Alexander H. Gunn, MD, Krunal Amin, MD, Carmelo Milano, MD   +8 more
doaj   +1 more source

A Case of HeartMate 3 Outflow Graft Twisting with Extraluminal Thrombosis: Is Computed Tomography Angiography Helpful? [PDF]

, 2020
Twists in the outflow graft of the HeartMateTM 3 device (Abbott) have recently been described as a sporadic, late complication. We present a case with a unique combination of external compression of the HeartMate 3 outflow graft by a surgical scar ...
Guglin, Maya, Saleb, Karim, Sekela, Michael, Zagurovskaya, Marianna   +3 more
core   +1 more source

Usefulness of regional right ventricular and right atrial strain for prediction of early and late right ventricular failure following a left ventricular assist device implant: A machine learning approach [PDF]

, 2019
Background: Identifying candidates for left ventricular assist device surgery at risk of right ventricular failure remains difficult. The aim was to identify the most accurate predictors of right ventricular failure among clinical, biological, and ...
Agnese V., Bellavia D., Clemenza F., Coronnello C., di Gesaro G., Falletta C., Gorcsan S. J., Iacovoni A., Maalouf J., Novo G., Pasta S., Pilato M., Sciacca S., Senni M., Simon M.   +14 more
core   +1 more source

Left ventricular assist device.

New England Journal of Medicine, 2002
To the Editor: The value of angiotensin-converting– enzyme (ACE) inhibitors, beta-blockers, and spironolactone has been well established by the results of numerous clinical trials. About 70 percent of the patients described by Rose et al. were treated with ACE inhibitors or angiotensin II–receptor antagonists; 35 to 40 percent received spironolactone ...
Jiménez-Navarro, Manuel, Molero, Encarnación, Teresa, Eduardo de   +2 more
openaire   +3 more sources

Feasibility of fast ventricular tachycardia mapping using the Rhythmia ™ system in a patient with an Impella ™

Indian Pacing and Electrophysiology Journal, 2020
Use of 3D navigation systems may be sometimes impossible in patients with left ventricular assist devices because of major electromagnetical interferences with some 3D systems based on magnetic localization. Mapping with the Rhythmia ™ system in patients
Philippe Maury, Maud Tabuteau, Quentin Voglimacci Stephanopoli, Anne Rollin, Clement Delmas   +4 more
doaj   +1 more source

Lessons Learned From a Delayed‐Start Trial of Modafinil for Freezing of Gait in Parkinson's Disease

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Freezing of gait (FOG) in people with Parkinson's disease (PwPD) is debilitating and has limited treatments. Modafinil modulates beta/gamma band activity in the pedunculopontine nucleus (PPN), like PPN deep brain stimulation. We therefore tested the hypothesis that Modafinil would improve FOG in PwPD.
Tuhin Virmani, Lakshmi Pillai, Reid D. Landes, Aliyah Glover, Shannon Doerhoff, Jennifer Kleiner, Mitesh Lotia, Rohit Dhall, Edgar Garcia‐Rill   +8 more
wiley   +1 more source